ADC Payload-Linker CMC Process Development Strategy
Hear Dr. Zheng Wei share a comprehensive payload-linker CMC development strategy that covers regulatory guidance, RSM selection, and stage-appropriate quality control to navigate the evolving complexities of ADC design from IND to NDA.
De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
In this webinar, Rico Buchli, PhD, shares how next-generation soluble HLA peptide discovery platforms can strengthen early immunotherapy R&D - from target identification and confirmation to receptor/drug validation and translational decision-making.
ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform — AmigoCHO™
Dr. Jiawen Xu presents AsymBio’s AmigoCHO™ platform and "CLD toolbox" strategies designed to accelerate cell line development and overcome CMC bottlenecks for complex antibody and ADC programs.
Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization
In this webinar, Vera Evanson, PhD presents how iPSC-derived ALS models reproduce hallmark disease phenotypes and their use in evaluating drug responses.
Building New Approach Methodologies for Angiogenesis and Vascularized Models
Join us for an insightful webinar exploring Lonza’s comprehensive portfolio of primary human cells and optimized media systems.
hiPSC-Cardiomyocyte Platforms Enabling Comprehensive Cardiac Toxicity and Drug Efficacy Evaluation
Join our webinar to discover how our hiPSC-cardiomyocyte platform can accelerate your drug discovery by enabling comprehensive evaluation - from QT interval to contractility, and from acute to chronic - for both cardiac toxicity and therapeutic efficacy!
Protein-Protein Interaction (PPI) Landscape – Sequence-to-Affinity Heatmaps for High-Throughput Antibody Optimization
In this webinar, Dr. Jihye Jo introduces PPI (protein-protein interaction) Landscape, powered by PROTEINA’s single-molecule SPID platform.
In Vivo panCAR™ Therapy Using Circular RNA for the Treatment of Autoimmune Disease
Learn how in vivo panCAR™ therapy, based on circular RNA and lipid nanoparticles, enables transient CAR expression and B cell depletion in preclinical models of autoimmune disease.
Human Biological Samples in Research: Quality, Compliance, and Clinical Relevance
In this webinar, three experts discuss best practices for ensuring specimen integrity, leveraging biobanking for oncology breakthroughs, and enriching clinical data for translational research.
From Single Domain to Single B: Leveraging Biointron’s Expertise for Antibody Discovery Success
In this webinar, we present Biointron’s proven expertise in two discovery approaches: VHH Phage Display for single-domain antibody generation and AbDrop® Single B Cell Screening for rapid antibody discovery.
Beyond Checkpoints: Strategic Use of CDX Models in Emerging IO Therapies
Learn how enhanced CDX models with humanized immune systems improve preclinical-to-clinical success in emerging immuno-oncology therapies.
Non CYP Mediated Metabolism Pathways and In Vitro Evaluation Strategies
Discover non-CYP metabolism pathways, key enzymes, and in vitro strategies for safer drug development in this webinar.
Building New Approach Methodologies (NAMs) and Complex In Vitro Assays
Learn how Lonza’s primary human cells, media, and reagents support advanced in vitro models for drug discovery, toxicity testing, and reducing animal use.
Optimizing Macrophage Polarization and Phagocytosis Assays
In this technical note, Lonza introduces a flexible, high-throughput workflow for generating and characterizing macrophage subtypes from cryopreserved PBMCs or CD14⁺ monocytes.
Enhance Your Tissue Processing Efficiency with the STEMprep™ Tissue Dissociator
Join Drs. Amanda Durkin and Grace Poon on October 2 as they explore how the STEMprep™ Tissue Dissociator System can simplify tissue processing and boost the efficiency of your biological research.
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
As the FDA and NIH encourage a shift away from animal testing, there’s growing momentum behind New Approach Methodologies (NAMs) — from advanced in vitro models to computational platforms. In this webinar, Concept Life Sciences and Delta4 present a powerful example of what this future looks like in practice.
Exploring the iPSC-Derived Neuronal-Glia Co-culture System: A Powerful Drug Discovery Platform for Studying Neurodegenerative Diseases
Learn how FUJIFILM’s iPSC-derived neuron-glia co-culture system supports drug discovery and disease modeling for neurodegenerative disorders.
Reprogramming Mouse Fibroblasts Into Induced Cardiomyocytes: Age-Related, Metabolic, and Epigenetic Barriers
Join Dr. Sandrina Nóbrega-Pereira as she discusses the role of age, epigenetics, and mitochondrial metabolism in the Direct Cardiac Conversion (DCC) of fibroblasts into induced cardiomyocytes (iCMs).
Vaccine-Boosting CAR T Cells Against Solid Tumors
Learn how a novel amphiphilic ligand boosts CAR T cells in vivo, enhances tumor targeting, and activates endogenous immunity—offering a promising new strategy for treating solid tumors.
Launch Event: Propelling Boundaries – Innovative Technologies in Early Drug Discovery
Join WuXi Biology Early Discovery Platform's experts as they discuss the innovative and latest technology updates in small and new molecule drug discovery.
Advances in Preclinical Research using Human Co-culture Models: Applications in Immunology, Infectious Disease, and Oncology
Join Dr. Ethan Shelkey as he discusses human primary co-culture models with immune cells that are used in infectious disease studies and cancer therapeutic testing.
The Hidden Variable in Your Intestinal Organoids: Enhancing Differentiation for a More Predictive Model
On June 4, 2025, Dr. Martin Stahl led a webinar exploring how cellular composition affects organoid performance in drug response and toxicity assays. He also introduced IntestiCult™ Plus Organoid Growth Medium, a next-generation organoid medium that supports simultaneous expansion and differentiation of intestinal organoids. Below are answers to audience questions from the session, edited for brevity and clarity.
Understanding Biological Material Licensing for Preclinical Research
Learn why biological material licensing matters in preclinical research, what risks to avoid, and how to manage licenses for cell lines, organoids, PDX models, and more.
CAR Finder – A Platform for Rapid CAR T Cell Screening
Dr. Sandy Tretbar introduces CAR Finder Technology and shares practical strategies to improve mRNA-based CAR T cell screening and selection.
The Link Between Mitochondrial Genetics and Immune Checkpoint Therapy in Melanoma
Discover how mitochondrial genetics influence the effectiveness of immune checkpoint inhibitors in treating melanoma, offering insights for personalized cancer therapies and potential new treatment avenues.
